COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,790 Articles (22,523 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 1672: Articles 16711-16720  | Next

Acceptability of COVID-19 vaccination among health care workers in Ghana
Agyekum, M. W., Afrifa-Anane, G. F., Kyei-Arthur, F., Addo, B.
10.1101/2021.03.11.21253374 — Posted: 2021-03-12
Airborne Transmission of COVID-19 and Mitigation Using Box Fan Air Cleaners in a Poorly Ventilated Classroom
He, R., Liu, W., Elson, J., Vogt, R., Maranville, C., Hong, J.
10.1101/2021.03.11.21253395 — Posted: 2021-03-12
Seroprevalence of SARS-CoV-2 Infection in Cincinnati Ohio USA from August to December 2020
Davis, G., York, A. J., Bacon, W. C., Lin, S.-C., McNeal, M. M., Yarawsky, A. E., Maciag, J. J., Miller, J. L. C., Locker, K. C. S., Bailey, M., Stone, R., Hall, M., Gonzalez, J., Sproles, A., Woodle, E. S., Safier, K., Justus, K. A., Spearman, P., Ware, R. E., Cancelas, J. A., Jordan, M. B., Herr, A. B., Hildamen, D. A., Molkentin, J. D.
10.1101/2021.03.11.21253263 — Posted: 2021-03-12
Oxygen provision to severely ill COVID-19 patients at the peak of the 2020 pandemic in a Swedish district hospital: medical records-based cohort study
Hvarfner, A., Al-Djaber, A., Ekstrom, H., Enarsson, M., Castegren, M., Baker, T., Schell, C. O.
10.1101/2021.03.11.21253350 — Posted: 2021-03-12
Day Camp in the Time of COVID-19: What Went Right?
Nachman, S., Brauner, G., Beleck, A., Handel, A. S.
10.1101/2021.03.11.21253309 — Posted: 2021-03-12
Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease: a cohort study across sixteen countries
Linschoten, M., Asselbergs, F. W., CAPACITY-COVID collaborative consortium, , LEOSS Study Group
10.1101/2021.03.11.21253106 — Posted: 2021-03-12
An international comparison of age and sex dependency of COVID-19 Deaths in 2020 - a descriptive analysis
Bauer, P., Brugger, J., Koenig, F., Posch, M.
10.1101/2021.03.11.21253420 — Posted: 2021-03-12
Pre-existing health conditions and severe COVID-19 infection: Analysis of commercial health insurance data from 690,000 infected patients
Wineinger, N. E., Li, V., Waalen, J., Topol, E. J.
10.1101/2021.03.11.21252708 — Posted: 2021-03-12
A novel whole-blood stimulation assay to detect and quantify memory T-cells in COVID-19 patients
Mouton, W., Compagnon, C., Saker, K., Daniel, S., Lacoux, X., Pozzetto, B., Oriol, G., Djebali, S., Berthier, F., Marvel, J., Walzer, T., Brengel-Pesce, K., Trouillet-Assant, S., COVID-ser study group
10.1101/2021.03.11.21253202 — Posted: 2021-03-12
Evaluation of anti-SARS-CoV-2 antibody testing in asymptomatic or mild COVID-19 patients in outbreak on a cruise ship
Kaku, N., Nishimura, F., Shigeishi, Y., Tachiki, R., Sakai, H., Sasaki, D., Ota, K., Sakamoto, K., Kosai, K., Hasegawa, H., Izumikawa, K., Ariyoshi, K., Mukae, H., Yasuda, J., Morita, K., Konno, S., Yanagihara, K.
10.1101/2021.03.10.21253064 — Posted: 2021-03-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).